- Home
- TK vs KALV Comparison
TK vs KALV Comparison
Compare TK & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- KALV
- Stock Information
- Founded
- TK 1973
- KALV N/A
- Country
- TK Bermuda
- KALV United States
- Employees
- TK N/A
- KALV N/A
- Industry
- TK Marine Transportation
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- TK Consumer Discretionary
- KALV Health Care
- Exchange
- TK Nasdaq
- KALV Nasdaq
- Market Cap
- TK 701.1M
- KALV 642.3M
- IPO Year
- TK 1995
- KALV N/A
- Fundamental
- Price
- TK $7.58
- KALV $15.39
- Analyst Decision
- TK
- KALV Strong Buy
- Analyst Count
- TK 0
- KALV 9
- Target Price
- TK N/A
- KALV $26.29
- AVG Volume (30 Days)
- TK 912.1K
- KALV 2.1M
- Earning Date
- TK 07-31-2025
- KALV 07-10-2025
- Dividend Yield
- TK 26.35%
- KALV N/A
- EPS Growth
- TK 13.88
- KALV N/A
- EPS
- TK 1.85
- KALV N/A
- Revenue
- TK $1,086,963,000.00
- KALV N/A
- Revenue This Year
- TK N/A
- KALV N/A
- Revenue Next Year
- TK N/A
- KALV $347.19
- P/E Ratio
- TK $4.13
- KALV N/A
- Revenue Growth
- TK N/A
- KALV N/A
- 52 Week Low
- TK $5.65
- KALV $7.30
- 52 Week High
- TK $9.78
- KALV $16.32
- Technical
- Relative Strength Index (RSI)
- TK 39.68
- KALV 66.25
- Support Level
- TK $7.44
- KALV $11.10
- Resistance Level
- TK $7.69
- KALV $16.20
- Average True Range (ATR)
- TK 0.25
- KALV 0.97
- MACD
- TK -0.06
- KALV 0.27
- Stochastic Oscillator
- TK 31.19
- KALV 91.19
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.